Vident Advisory’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,028
Closed -$54.7K 2036
2026
Q1
$54.7K Sell
10,028
-384
-4% -$2.15K ﹤0.01% 1816
2025
Q4
$72.9K Buy
10,412
+294
+3% +$2.3K ﹤0.01% 1600
2025
Q3
$78.2K Buy
+10,118
New +$79K ﹤0.01% 1608
2024
Q4
Sell
-10,730
Closed -$98.5K 1542
2024
Q3
$98.5K Sell
10,730
-18,892
-64% -$156K ﹤0.01% 1375
2024
Q2
$290K Buy
+29,622
New +$361K 0.01% 1139
2024
Q1
Sell
-24,909
Closed -$537K 1416
2023
Q4
$537K Sell
24,909
-3,160
-11% -$58.3K 0.01% 755
2023
Q3
$522K Buy
+28,069
New +$655K 0.02% 688

Other funds holding TDOC

Vident Advisory's TDOC Position: Q2 2026 in Review

Vident Advisory sold out of Teladoc Health (TDOC) in Q2 2026, closing a stake of 10,028 shares — an estimated $54.7K sold.

Vident Advisory first reported a position in TDOC in Q3 2023 and held it in 7 quarters. The position peaked at $537K in Q4 2023. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Vident Advisory reported no remaining Teladoc Health position as of Q2 2026 after selling out during the quarter.
  • Vident Advisory sold 10,028 Teladoc Health shares in Q2 2026, an estimated $54.7K.
  • Vident Advisory first reported a position in Teladoc Health in Q3 2023 and held it in 7 quarters.
  • Vident Advisory's Teladoc Health position peaked at $537K in Q4 2023.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.